DPX Technologies Joins Biotage, Enabling Biotage to Provide Industry Leading Pipette Tip Technology and Applications

Biotage, a global supplier and solutions partner to a wide range of customers within drug discovery and development and analytical testing, today announced that it has acquired DPX Technologies, an industry-leading Pipette Tip Technology and Applications company, effective Wednesday, 31 December 2025. The acquisition strengthens Biotage’s position within sample prep and expands its capabilities in pipette tip technology.

DPX Technologies is located in Columbia, SC, USA and has 45 employees in USA who will join Biotage. It successfully serves a wide range of customers in the clinical, forensic, genomics, proteomics and food safety industries through its easy-to-use and easy-to-automate pipette tips.

Frederic Vanderhaegen, CEO and President at Biotage, said: “This decision results from our clear strategic ambition to strengthen Biotage leadership in analytical testing. It will expand our offering in the high growth sample preparation segments. DPX pioneered dispersive extraction is a natural fit within our existing capabilities. Beyond the product fit, there is a clear cultural alignment between our companies. I am thrilled to welcome the DPX Technology team and combine our strengths to accelerate growth and bring enhanced value to customers.”

DPX Technologies will continue to operate under its existing management, during an integration period. Customers, partners, and suppliers will experience no changes to day-to-day operations, points of contact, or ongoing projects in the near term.

Dr. William Brewer, President and CEO of DPX Technologies comments on the transaction: “Biotage is an ideal fit for our company. Our pipette tip-based sample preparation products are complimentary to the numerous products and applications already offered by Biotage. By combining our businesses, our technologies will provide better and more efficient outcomes for our customers, leading to faster drug discoveries and clinical diagnoses, ultimately saving lives.”

For more information please contact:

Frederic Vanderhaegen – Chief Executive Officer

+41 797 600 543

ir@biotage.com

# # #

About DPX Technologies

DPX Technologies is a leading provider of automated solutions for food safety testing, clinical laboratory testing, cannabis testing, forensic toxicology, genomics and proteomics sample preparation. DPX is committed to providing innovative sample purification solutions that increase efficiencies, unleashing the potential for scientists to solve problems with chemistry. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis.

About Biotage

Biotage is a global supplier and solutions partner to a wide range of customers within Drug Discovery and Development and Analytical Testing. With expertise in separation and purification technology and leveraging intelligent workflow solutions, the group aims to be the best partner advancing health solutions.

Headquartered in Sweden, Biotage operates globally serving over 80 countries.

www.biotage.com

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.